
Regen Biologix offers advanced IV and injectable peptide therapies designed to help your body heal, repair, and thrive. Whether you're looking to reverse signs of aging, accelerate injury recovery, or enhance metabolic function, our clinical peptide protocols are tailored to your unique goals.

Peptide therapy involves using short chains of amino acids that signal your body to perform specific regenerative functions. These bioactive peptides mimic natural biological processes, helping stimulate growth hormone production, repair tissues, reduce inflammation, and support metabolic health. At Regen Biologix, we administer peptides through IV infusions and subcutaneous injections, ensuring direct absorption and rapid results.

We offer evidence-based peptides including:
Each peptide is carefully dosed according to clinical best practices based on your condition and goals.
We customize your treatment protocol from a broad library of clinically backed peptides, including:

Each peptide comes with precise dosage, timeline, and washout period, and is overseen by a licensed Regen Biologix clinician.
Our licensed practitioners administer peptides subcutaneously (via insulin syringes) or intravenously, depending on the therapy. Treatment protocols follow medical guidelines, with cycles ranging from 4 to 20 weeks. All injections are performed in a clinical setting with full monitoring to ensure your safety and optimize results.
We tailor every peptide program based on your biometrics, medical history, and outcome goals. Our in-house team performs full assessments before recommending a combination of therapies for optimal performance, vitality, and longevity.

Our IV peptide protocols target:
Some peptides like PT-141 (Vyleesi) are FDA-approved for specific uses. Many others are used off-label based on strong clinical evidence and are compounded in licensed pharmacies.
Most peptides are well-tolerated. Mild side effects may include redness at the injection site, increased hunger, fatigue, or headache. Your clinician will monitor for reactions and adjust dosing if needed.
Absolutely. Peptides often complement IV nutrient therapy, stem cell treatments, or EBOO therapy for enhanced cellular recovery and immune support.
Results vary, but most clients begin noticing improvements in energy, recovery, or metabolism within 2–4 weeks of starting therapy.
Subcutaneous injections are most common and effective for peptides. However, NAD+ and certain nutrient peptides may be delivered more efficiently via IV.
The Glucose-6-Phosphate Dehydrogenase (G6PD) Test measures enzyme activity to detect G6PD deficiency, a genetic condition that can lead to hemolytic anemia when exposed to certain foods, infections, or medications. Doctors order this test to assess unexplained anemia, jaundice, or family history of G6PD deficiency. Results help identify individuals at risk for red blood cell breakdown, guiding treatment, prevention, and safe medication use.
Specimen: Blood
Collection: Blood Draw
Also Known As: Glucose-6-Phosphate Dehydrogenase Test, G6PD Enzyme Test, G6PD Deficiency Test
Book NowThe SARS-CoV-2 Total Antibody Spike Semi-Quantitative Test detects antibodies to the COVID-19 spike protein, indicating an adaptive immune response from recent or prior infection. Vaccinated individuals may also test positive, though results should not be used to assess immunity or protection. Doctors use this blood test to confirm past exposure, but it is not designed to diagnose active infection or predict reinfection risk.
Specimen: Blood
Collection: Blood Draw
Also Known As: COVID-19 Spike Test
Book Now